Inbrija 42 mg/1
levodopa · CAPSULE · Merz Pharmaceuticals, LLC
No Recall History
Plain English
Inbrija is a capsule containing levodopa at 42 mg/1, taken respiratory (inhalation). Manufactured by Merz Pharmaceuticals, LLC.
Key Facts
- Brand Name
- Inbrija
- Generic Name
- levodopa
- NDC Code (Product)
10144-342- Manufacturer
- Merz Pharmaceuticals, LLC
- Strength
- 42 mg/1
- Dosage Form
- CAPSULE
- Route
- RESPIRATORY (INHALATION)
- Marketing Status
- Application #
- NDA209184
- Drug Class
- Aromatic Amino Acid [EPC]
- Marketing Start
- 12/22/2018
Recall History
No Recall HistoryFrequently Asked Questions
What is Inbrija used for?
Inbrija contains levodopa. It is a capsule taken respiratory (inhalation). Consult your doctor for specific uses.
Is Inbrija a controlled substance?
Inbrija is not classified as a controlled substance by the DEA.
What is the generic name for Inbrija?
The generic name for Inbrija is levodopa. There are no other listed brand versions of levodopa.
What is the NDC code for Inbrija 42 mg/1?
The NDC (National Drug Code) for Inbrija 42 mg/1 is 10144-342, listed by Merz Pharmaceuticals, LLC.
Other Inbrija Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)